SCHEMBL479632

SCHEMBL479632

CCOC(=O)c1ccc2c(c1)NC(=O)/C2=C\Nc1ccc(N(C)C(=O)CN(C)C)c(NC(C)=O)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKB Q96GD4 2/20 0.37
RXFP1 Q9HBX9 1/20 0.37
ALDH1A1 P00352 2/20 0.37
KMT2A Q03164 2/20 0.36
CSF1R P07333 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
MAPT P10636 2/20 0.34
TP53 P04637 2/20 0.34
POLB P06746 2/20 0.34
FLT3 P36888 2/20 0.33
NTRK3 Q16288 1/20 0.33
KDR P35968 1/20 0.33
ABL1 P00519 1/20 0.33
RET P07949 1/20 0.33
PDGFRB P09619 1/20 0.33
FGFR1 P11362 1/20 0.33
ALK Q9UM73 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL479631 1.00 AURKB (0.37) AURKBRXFP1ALDH1A1KMT2ACSF1R
SCHEMBL480621 0.85 ALDH1A1 (0.43) AURKBRXFP1ALDH1A1KMT2ACSF1R
SCHEMBL3153364 0.85 ALDH1A1 (0.43) AURKBRXFP1ALDH1A1KMT2ACSF1R
SCHEMBL2569434 0.82 RXFP1 (0.39) RXFP1ALDH1A1KMT2ASMN1; SMN2NPC1
SCHEMBL2569433 0.82 RXFP1 (0.39) RXFP1ALDH1A1KMT2ASMN1; SMN2NPC1
SCHEMBL479789 0.79 ALDH1A1 (0.46) RXFP1ALDH1A1KMT2ACSF1RSMN1; SMN2
SCHEMBL479791 0.79 ALDH1A1 (0.46) RXFP1ALDH1A1KMT2ACSF1RSMN1; SMN2
SCHEMBL2567922 0.79 ALDH1A1 (0.46) RXFP1ALDH1A1KMT2ACSF1RSMN1; SMN2
SCHEMBL479417 0.78 AURKA (0.41) AURKBALDH1A1KMT2ACSF1RFLT3
SCHEMBL2563861 0.78 AURKA (0.41) AURKBALDH1A1KMT2ACSF1RFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9844572-B2 Promotion of neuronal integration in neural stem cell grafts LIFE & BRAIN GMBH (DE) 2017-12-19 US disclosed
EP-2411034-B1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS LIFE & BRAIN GMBH (DE) 2017-07-26 EP disclosed
US-20120093832-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS LIFE & BRAIN GMBH (DE) 2012-04-19 US disclosed
EP-2411034-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS Life & Brain GmbH (DE) 2012-02-01 EP disclosed
WO-2010108665-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS LIFE & BRAIN GMBH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120093832-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS DCX, NGF, BDNF AURKB 4054/4885RXFP1 2731/4885ALDH1A1 175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.